Literature DB >> 27255469

The Bone Microenvironment: a Fertile Soil for Tumor Growth.

Denise Buenrostro1,2,3, Patrick L Mulcrone2,3, Philip Owens3, Julie A Sterling4,5,6,7.   

Abstract

Bone metastatic disease remains a significant and frequent problem for cancer patients that can lead to increased morbidity and mortality. Unfortunately, despite decades of research, bone metastases remain incurable. Current studies have demonstrated that many properties and cell types within the bone and bone marrow microenvironment contribute to tumor-induced bone disease. Furthermore, they have pointed to the importance of understanding how tumor cells interact with their microenvironment in order to help improve both the development of new therapeutics and the prediction of response to therapy.

Entities:  

Keywords:  Bisphosphonates; Bone microenvironment; Immune cells; Nervous system; Tumor-induced bone disease; Vasculature

Mesh:

Year:  2016        PMID: 27255469      PMCID: PMC4927340          DOI: 10.1007/s11914-016-0315-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  97 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Authors:  Moshe Elkabets; Vera S G Ribeiro; Charles A Dinarello; Suzanne Ostrand-Rosenberg; James P Di Santo; Ron N Apte; Christian A J Vosshenrich
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

3.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

4.  Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model.

Authors:  Kylie A Alexander; Ming K Chang; Erin R Maylin; Thomas Kohler; Ralph Müller; Andy C Wu; Nico Van Rooijen; Matthew J Sweet; David A Hume; Liza J Raggatt; Allison R Pettit
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

5.  Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.

Authors:  Scott A Bergfeld; Laurence Blavier; Yves A DeClerck
Journal:  Mol Cancer Ther       Date:  2014-02-06       Impact factor: 6.261

6.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.

Authors:  Dori A Thomas; Joan Massagué
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

7.  Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.

Authors:  Robert Coleman; David Cameron; David Dodwell; Richard Bell; Caroline Wilson; Emma Rathbone; Maccon Keane; Miguel Gil; Roger Burkinshaw; Robert Grieve; Peter Barrett-Lee; Diana Ritchie; Victoria Liversedge; Samantha Hinsley; Helen Marshall
Journal:  Lancet Oncol       Date:  2014-07-15       Impact factor: 41.316

Review 8.  Do stress-related psychosocial factors contribute to cancer incidence and survival?

Authors:  Yoichi Chida; Mark Hamer; Jane Wardle; Andrew Steptoe
Journal:  Nat Clin Pract Oncol       Date:  2008-05-20

9.  T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer.

Authors:  Ana Carolina Monteiro; Ana Carolina Leal; Triciana Gonçalves-Silva; Ana Carolina T Mercadante; Fabiola Kestelman; Sacha Braun Chaves; Ricardo Bentes Azevedo; João P Monteiro; Adriana Bonomo
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  21 in total

Review 1.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

2.  Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.

Authors:  Denise Buenrostro; Kristin A Kwakwa; Nicole E Putnam; Alyssa R Merkel; Joshua R Johnson; James E Cassat; Julie A Sterling
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

Review 3.  Osteoblastic Factors in Prostate Cancer Bone Metastasis.

Authors:  Song-Chang Lin; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 4.  Integrin αvβ3 Signaling in Tumor-Induced Bone Disease.

Authors:  Kristin A Kwakwa; Julie A Sterling
Journal:  Cancers (Basel)       Date:  2017-07-08       Impact factor: 6.639

Review 5.  The plasticity of germ cell cancers and its dependence on the cellular microenvironment.

Authors:  Daniel Nettersheim; Hubert Schorle
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

6.  Sodium butyrate has anti-proliferative, pro-differentiating, and immunomodulatory effects in osteosarcoma cells and counteracts the TNFα-induced low-grade inflammation.

Authors:  Silvia Perego; Veronica Sansoni; Giuseppe Banfi; Giovanni Lombardi
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

Review 7.  The Emerging Role of Osteocytes in Cancer in Bone.

Authors:  Emily G Atkinson; Jesús Delgado-Calle
Journal:  JBMR Plus       Date:  2019-02-27

Review 8.  The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone.

Authors:  Andy Göbel; Stefania Dell'Endice; Nikolai Jaschke; Sophie Pählig; Amna Shahid; Lorenz C Hofbauer; Tilman D Rachner
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone.

Authors:  Milene N O Moritz; Alyssa R Merkel; Ean G Feldman; Heloisa S Selistre-de-Araujo; Julie A Rhoades Sterling
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 10.  Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?

Authors:  Sandra Casimiro; Arlindo R Ferreira; André Mansinho; Irina Alho; Luis Costa
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.